Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)

When measuring outcomes in systemic lupus erythematosus (SLE), it is important for clinicians to monitor disease activity, health-related quality of life, and any irreversible change in the organ system that occurred since the onset of SLE. While there are currently many therapies utilized in treating SLE, such as nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antimalarials, immunosuppressants, chemotherapy, biologics, and adjunctive therapies, there are still unmet needs with a mort...
CME Outfitters

Immune Pathways in Systemic Lupus Erythematosus (SLE)

Lupus is a prototypic autoimmune disease with highly heterogeneous manifestations and variable disease activity in which no two cases are alike. Differences can be caused by genetics and epigenetics, pathogenetic mechanisms, demographics, ethnicity and race, as well as socioeconomic factors, and disease heterogeneity can cause challenges with development and selection of therapeutics, perfection of clinical trial designs, and prognostication. The first episode of this CMEOCast podcast serie...
CME Outfitters

Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis

Understanding patient preferences, values, and needs is essential to patient satisfaction and patient-centered care. Whether via telehealth or in-office treatment, today’s patients and their families want to be engaged in their care. This involves inclusion in personalized decision-making, education about their disease and treatment options, updates on care progress, and arriving at treatment decisions together. The final episode of this CMEOCast podcast series on psoriatic arthritis (PsA...
CME Outfitters

Adding Tools to the Toolbox: New and Emerging Treatments for Psoriatic Arthritis

The principles of psoriatic arthritis (PsA) treatment include reducing pain, improving quality of life, preventing structural damage and complications, engaging patients in shared decision-making, and identifying comorbidities that may impact treatment decisions. This requires management by a multidisciplinary team. Novel agents and treatment targets have demonstrated efficacy in PsA. Education is needed to ensure that the most up-to-date evidence informs treatment decision-making to optimize ...
CME Outfitters

Eliminating Diagnostic Delays in Psoriatic Arthritis

Psoriatic arthritis (PsA) is a progressive, erosive, chronic, heterogeneous, systemic inflammatory disease affecting six different clinical domains and presents in up to 30% of patients with psoriasis (PsO). Beyond issues caused with joints and skin, PsA can also lead to fatigue, poor sleep quality, diminished work capacity, physical function limitations, and decreased social participation. Early detection and treatment are critical for improving long-term patient outcomes and minimizing irrev...
CME Outfitters

Evidence-Based Strategies to Improve Access to Therapies for Patients with Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is both a rare disease and the most common fatal genetic disease of infancy. The approval of the first disease-modifying therapy (DMT) for SMA in 2016 revolutionized management, and treatment options have expanded with two additional DMTs approved more recently. However, because SMA is a rare disease, many clinicians and payers have limited knowledge of SMA and the available DMTs, which can contribute to delays in diagnosis and treatment initiation. Evidence-based...
CME Outfitters

Unique Approaches to the Management of Underserved Patients with IBD

There are many disparities in irritable bowel disease (IBD) care, with an incidence rate of IBD hospitalization that is 4x higher in patients with low socio-economic status and a 3x increased ratio of IBD hospitalizations and mortality in Blacks compared to Whites and Hispanics. The final episode of this CMEOCast podcast series summarizes the discussion points on the racial/ethnic and economic inequality in IBD and offers approaches to mitigate disparities on the level of both individual he...
CME Outfitters

The Role of Socioeconomic Factors in Health Care Delivery in IBD

Certain patients with IBD are more likely to see poor outcomes due to low socioeconomic status (SES). Recognizing and acting on these differences is especially important during the COVID-19 pandemic, the economic consequences of which have disproportionately affected those with low SES. In the second episode of this CMEOCast podcast series, expert faculty focus on the role of SES and gender bias in the treatment of IBD and offer approaches to mitigating these disparities. - Learning Obje...
CME Outfitters

The Role of Race in Health Care Delivery in IBD

Although IBD is more common in non-Hispanic Whites compared to other racial groups, there is a disproportionately higher ratio of hospitalizations, surgery, and IBD-related mortality among non-Hispanic African Americans compared with other racial groups. This fact, in addition to the rising prevalence of IBD in North America and the estimate that 54% of the U.S. population will be comprised of minority populations by 2050, underscores the need for high-quality treatment available to racial and...
CME Outfitters

Coronavirus Disease 2019 (COVID-19) and Inflammatory Bowel Disease

The COVID-19 pandemic created many challenges and uncertainty in our healthcare system. One component facing clinicians managing patients with inflammatory bowel disease (IBD) is whether or not to continue providing certain pharmacotherapies in patients who are at increased risk of infection because they are immunocompromised. The consensus of gastroenterologists is that decisions should be made on a case-by-case basis, but that overall, uncontrolled disease activity and inflammation present m...
CME Outfitters

Long-Term Management of HBV: Meeting the Culturally Diverse Needs of Your Patient Community

Despite the high prevalence of hepatitis B virus (HBV) in the United States, only 32% of patients are aware of their HBV status and less than 30% receive treatment. There are six groups who are at especially high risk: foreign-born Asian/Pacific Islanders, Africa-born Black populations, incarcerated persons, people who inject drugs, men who have sex with men, and refugees. Disease awareness is especially low in many of these populations. In conjunction, the disease burden is compounded by cult...
CME Outfitters

Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care

Screening for hepatitis B virus (HBV) in the emergency department (ED) is an important public health opportunity, as it can reduce transmission in high-risk patients and facilitate linkage to care. HBV testing can be included when screening for sexually transmitted infections (STIs) and hepatitis C virus (HCV), and emergency department (ED) physicians to employ strategies for follow-up, including treatment or vaccination, after receiving HBV results. The third episode of this CMEOCast podca...
CME Outfitters

HBV Treatment Decision-Making

Chronic hepatitis B virus (HBV) is a serious public health concern that is often underrated despite the approval of newer therapies and subsequent updated guidelines. Integrating guideline-directed treatment can reduce the morbidity and mortality associated with HBV. In this second episode of the four-part CMEOCast Podcast to Practice series "Meeting Patients Where They Live: Community-Based Efforts to Improve Screening and Treatment of HBV," faculty experts will discuss the efficacy and sa...
CME Outfitters

The HBV Refresher: Screen, Diagnose, Treat

Despite updated guidance from the American Association for the Study of Liver Diseases (AASLD) on the prevention, diagnosis, and treatment of chronic hepatitis B virus (HBV), early detection and implementation of effective treatment remains a challenge. The first episode of this CMEOcast series on community-based efforts to improve screening and treatment of HBV will guide primary care clinicians through optimal strategies to screen for HBV in at-risk patients and utilize serological test r...
CME Outfitters

Differentiators When Choosing Novel Treatment Options for EDS

Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In order to achieve reduced EDS, cataplexy and sleep paralysis/hypnagogic hallucinations must be controlled to improve disturbed nighttime sleep, which then improves fatigue and brain fog and reduces psychosocial dysfunction, therefore improving quality of life (QoL). The latest efficacy and safety data should be reviewed, and considerations for treatment se...
CME Outfitters

Matching Treatment Choice to the Pathophysiology of Sleep

The neurobiology of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) has no identified pathophysiology. This can make it difficult for clinicians to determine a target for therapeutic intervention; therefore, awareness of the mechanisms of action of current and novel therapies is vital when selecting an optimal treatment. In the second episode of this CME Outfitters podcast series on EDS, expert faculty will focus on identifying key neurotransmitters involved in the sleep...
CME Outfitters

Implementing a Shingles Protocol in Pharmacies

Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles vaccination remains low. Community pharmacists play a critical role in educating at-risk patients abou...
CME Outfitters

COVID-19 and Rheumatology Care: How Does it Impact My Patients?

Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field that provide the dimension and context needed to interpret the latest data and guidance. This C...

Best Practices for Incorporating LAIs into Treatment Planning for Schizophrenia

Schizophrenia is an all-too-often chronic, debilitating disorder that impedes quality of life and psychosocial functioning. Implementation of effective therapy that promotes sustained recovery often poses a challenge for both clinicians and patients. Long-acting injectables (LAIs) can play a critical role in relapse prevention and rehospitalization, and subsequently, recovery and restoration of function. This CME Outfitters BriefCase will guide clinicians through best practices to identify ...
CME Outfitters

From Bench to Bedside: Applying Clinical Updates to Schizophrenia Management

Per APA Guidelines, treatment goals for schizophrenia include avoiding relapses and exacerbations that can cause immense negative impact on quality of life (QoL). Long-acting injectables (LAIs) are an effective tool for achieving these goals in both acute and chronic phases of illness; however, there is often reluctance to implement their use. A better understanding of the safety and efficacy of LAIs, particularly in comparison to their oral counterparts, can improve treatment decisions for in...
CME Outfitters

Joining Forces in the Coordination of Care of Patients with Psoriatic Arthritis

Delays in diagnosing psoriatic arthritis (PsA) are common, with the median lag time from disease onset to a confirmatory diagnosis being 2.5 years. It is imperative that clinicians recognize the impact of delays in diagnosis on joint damage and patient quality of life, and that a multidisciplinary approach can help with earlier diagnosis and better management of PsA and its comorbidities. The final installment of this CME Outfitters Snack series on managing PsA features discussion on the in...
CME Outfitters

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

Psoriatic arthritis (PsA) can have serious debilitating effects on peripheral joints, the spine, tendon insertions, and fingers. Management of PsA has improved with therapies such as nonpharmacologic and symptomatic treatments, oral small molecules, tumor necrosis factor inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, CTLA4-lg, Janus kinase (JAK)/TyK2 inhibitors, and IL-23 inhibitors; however, complete disease control has not yet been achieved. This CME Outfitters Snack foc...
CME Outfitters

Pathogenesis of Psoriatic Arthritis: A Broader Understanding to Inform Next Steps

Psoriatic arthritis (PsA) presents in up to 30% of patients with psoriasis (PsO) and may precede, occur concurrently with, or occur after the development of PsO. It is imperative to recognize that PsA can present in the dermatology or rheumatology clinic depending on the primary symptom and that clinicians then accurately diagnose PsA by utilizing screening questionnaires, as well as screening patients with PsA for common comorbidities. The first episode of this CME Outfitters Snack series ...
CME Outfitters

Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management

Osteoarthritis (OA) is the most common form of arthritis, affecting 1 in 3 people over the age of 65. It is the third most rapidly rising cause of disability and the most common reason for decrease in ambulation. With the onset of the COVID-19 pandemic, the US Surgeon General has recommended cancelling elective surgeries, causing a large impact on patients with OA. A survey of 360 patients at 6 surgical centers who had to cancel their hip or knee surgery revealed that 30% would have surgery de...
CME Outfitters

Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis

Previously, osteoarthritis (OA) was thought to be a disease of chronic overload and impaired biomechanics on the joint that lead to the destruction of the joint's article cartilage, resulting in inflammation. However, evolving theories link OA to complex inflammatory and metabolic factors, and inadequate pain relief with current treatments is a common aspect of OA treatment which is responsible for a plethora of health care visits and dollars. Additionally, there are concerns about the risks o...
CME Outfitters

Finding Function: A Holistic Approach to Managing Osteoarthritis

There are several different approaches to treating osteoarthritis (OA), including physical, psychosocial, and mind-body. It is important that primary care physicians work in concert with rheumatologists, physical/occupational therapists, psychologists, and dietitians to create a multidisciplinary management plan for their patients with OA, as well as participating in shared decision-making. In this installment of the CME Outfitters Snack series on managing osteoarthritis, expert faculty dis...
CME Outfitters

Seeing Osteoarthritis Management Through a New Mechanistic Lens

Inadequate pain relief despite current treatments is one of the most troubling aspects of osteoarthritis (OA), and is responsible for the majority of health care visits in patients with OA. Additional concerns about the risks of long-term NSAID and opiate use contribute to unmet treatment needs. It is therefore necessary for clinicians to recognize the role of novel targets for pain management, particularly nerve growth factor, and to evaluate the efficacy and safety of novel mechanisms of act...
CME Outfitters

Weighing the Heavy Burden of Osteoarthritis: Improving Function and Quality of Life

The burden of osteoarthritis (OA) is a heavy one, often leading to poor quality of life (QoL) due to functional limitations and loss of independence, poor sleep quality, fatigue, depressed mood, and increased healthcare expenditures. Additionally, comorbidities such as stroke, peptic ulcer, and metabolic syndrome must be considered. Therefore, proper assessment of a patient's OA, the pain it causes, and the proper utilization of tools such as GAD-7 and PHQ-9 to assess anxiety and depression, a...
CME Outfitters

Signals of Change in the Management of Atopic Dermatitis

Atopic dermatitis (AD) is a chronic, inflammatory skin disease that effects up to 18% of children and up to 10% of adults and can have a substantial negative impact on the quality of life (QoL) of patients and their families. Its management is challenging at any age, with patients and caregivers often becoming overwhelmed by the chronic and relapsing nature of AD. Establishing disease severity is essential to inform treatment decisions, as is information on new clinical trial data for therapie...
CME Outfitters

Unlocking the Value of Biosimilar Therapies in IBD

Over the years, biologic agents have proven their importance in the management of chronic autoimmune diseases including inflammatory bowel disease (IBD). Biosimilars are molecules highly similar to approved biologic medicines that have been developed to mitigate the high costs of biologics. Despite the fact that these therapies are tested to ensure non-inferiority to originator products, questions about appropriate use of biosiilars in IBD remain among clinicians and patients alike. In this...
CME Outfitters

Rethinking Routines in Multiple Sclerosis Management: What the Future Holds for DMTs and Cognitive Assessment Strategies

Multiple sclerosis (MS) is a chronic inflammatory and neurological disease that is the leading cause of disability in young and middle-aged people in the United States. The number of disease-modifying therapies (DMTs) available for treatment of MS has expanded in recent years, and it is imperative that neurologists and other health care professionals (HCPs) have up-to-date knowledge of clinical efficacy and safety of these therapeutic agents to inform individualized treatment decisions. Cog...
CME Outfitters

Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer. Faculty provide practical guidance to apply available and emerging data in real-world decision-making that clinicians are faced with on a daily basis including: interpreting results to inform treatment decisions, biomarker testing, patient selection, and combination therapy. Video modules are also available as do...

VTE Prophylaxis in Acutely Ill Medical Patients

What is the latest evidence for VTE prophylaxis in acutely ill medical patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention in this key patient group. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice.

Closing in on Post-Thrombotic Syndrome: The Latest Updates

Dr. Kush Desai from Northwestern Medicine and Dr. Erin Murphy from Sanger Heart and Vascular, Atrium Health discuss the latest updates in post-thrombotic syndrome (PTS) including a review on the newer venous stents as well as limitations with conservative therapies in this targeted 30-minute CME eNewsletter. The touchpoint also features images, easy-to-read charts and graphs and feature their expert perspectives on the treatment of PTS, the benefits of venous stenting, as well as the best foll...

Burnout-Prevention and Coping Tactics for Oncologists

This episode of Oncology Data Advisor with Daniel McFarland, DO, Northwell Health Lenox Hill Hospital, focuses on physician burnout, work-related stress, and the effects, including depression and exhaustion, that many physicians are facing from the challenges of the COVID-19 pandemic. Listen now to learn new strategies to combat these challenges! STATEMENT OF NEED Physician burnout and work-related stress are serious and prevalent issues in oncology, with nearly 45% of oncologists experi...
i3 Health

Career Advancement and Leadership Skills for Women in Healthcare - LIVE STREAM

Strategies and Skills Development for Career Advancement and Leadership Career Advancement and Leadership Skills for Women in Healthcare will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. This Harvard Medical School professional development program, which sells out every year, delivers evidence-based strategies, skills development and education that help women at various stages of their healthcare careers step into and succeed in lead...
Harvard Medical School

Intensive Review of Nephrology - LIVE STREAMING

With over 70 interactive lectures, case discussions, board preparation sessions, and supplementary lectures, this CME program provides a comprehensive review of state-of-the-art nephrology practices offered by the clinical faculty of Harvard Medical School. It offers accelerated learning for: ► Clinicians seeking a practical and comprehensive review that ensures they are up to date across all major areas of nephrology: • The latest options for diagnosis: what to choose, when, and why...
Harvard Medical School

Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders

Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications and devices, includi...
Annenberg Center for Health Sciences at Eisenhower

Matching Treatment Options to the Patient: The Role of Botulinum Toxin in Pediatric Patients with Spasticity

Spasticity, a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, results from hyper excitability of the stretch reflex. It often causes damage to one or more areas of the central nervous system; therefore, treatment goals should aim to provide symptom relief, ease patient care and decrease caregiver burden, and improve patient function. In order to accomplish these goals, it is imperative that clinicians develop individualized...
CME Outfitters

17th Annual Mayo Clinic Women’s Health Update – Live/Livestream

This three-day conference will offer a hybrid format (Live and livestream), addressing a variety of topics including contraception, sexual health, menopause and other hormonal issues, breast health, LGBT health, cosmetic dermatology, general medical conditions in women and more. Interactive Q & A panel discussions with the faculty, reinforced by evidence-supported and case-based presentations, ensure this program is one not to miss. The course format will include the use of interactive votin...
Mayo Clinic

2021 International Congress on Myeloproliferative Neoplasms

This year marks the 20th Anniversary of the International Congress on Myeloproliferative Neoplasms (MPN Congress), which has become very popular over the past two decades- providing timely, relevant and meaningful information concerning the diagnosis and treatment of myeloproliferative neoplasms to attendees from around the world. The highly anticipated MPN Congress has always emphasized faculty interaction, audience participation and personal, collegial discussion among attendees, all of whic...
Melton Medical Education, LLC

Update in Clinical Cardiology - LIVE STREAM

The Comprehensive Clinical Cardiology Update Evaluation • Treatment • Procedures • Challenging Cases • COVID-19 Update in Clinical Cardiology will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. OVERVIEW This course provides a comprehensive review of state-of-the-art practices to diagnose and treat patients with cardiovascular conditions. Led by the leading clinical faculty of Harvard Medical School and the Massachusetts Gene...
Harvard Medical School

Intensive Review of Internal Medicine - LIVE STREAMING

The Acclaimed Clinical Update and Board Review LIVE STREAMING and ON-DEMAND EDUCATION The 44th annual Intensive Review of Internal Medicine is presented in 2021 as a distance learning program featuring: • Live streaming education that provides strategies for state-of-the-art care in today’s healthcare environment • Updates across all major areas of Internal Medicine • Online, interactive Q&A with the clinical leaders who are providing these updates • A new library of pr...
Harvard Medical School

32nd Annual Cardiovascular Interventions

The Cardiovascular Interventions symposium will provide the practicing physician and cardiovascular care team with a concentrated exposure to new developments in interventional cardiology with the goal of positively influencing patient outcomes. The agenda will include 20 complex live cases, lectures from world renowned experts, satellite programs on the latest technologies, and many participant-faculty interactions.
Promedica International CME

Breakthroughs for Obese Patients with VTE

What is the latest evidence for VTE prophylaxis and treatment in obese patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention and management. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice.

A Step in the Right Direction: Updates for Your PAD Patients Post-Revascularization

For your patients with PAD post-revascularization, what can you do to ensure the next “steps in the right direction”? In this activity, expert faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. Roundtable discussion is included to provide practical insight for clinicians to apply knowledge to their practice.

In Limb-O: Improving CAD and PAD Care in the Stably Unstable

Unprotected, your patients with CAD and PAD are on the edge, in “limb-o” – how do we get them to become more in balance? In this activity, expert multidisciplinary faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. A patient case is woven throughout this discussion to increase opportunities for clinicians to apply knowledge to their practice.

Best of the Big Apple OB-GYN Ultrasound 2021

Held annually in New York City, the Best of the Big Apple OB-GYN Ultrasound 2021 event will be held at the Crowne Plaza Times Square Manhattan. 19.25 AMA PRA Category 1 Credits™ Cognate Credits are pending approval Category A CE Credit approval is pending This course is designed for physicians and sonographers in the fields of gynecologic and obstetric imaging, as well as residents in obstetrics and gynecology, or radiology, and fellows in maternal-fetal medicine. This course may ...
World Class CME

Fetal and Women's Imaging 2021 - Advanced OB-GYN Ultrasound

World Class CME is again proud to host the annual Fetal and Women's Imaging conference in Seattle, Washington. We welcome everyone to The Westin Seattle for yet another excellent three day course in 2021. This course is designed for physicians and sonographers in the fields of gynecologic and obstetric imaging, as well as residents in obstetrics and gynecology, or radiology, and fellows in maternal-fetal medicine. This course may also be valuable to family physicians practicing obstetrics, ...
World Class CME

Decisions in Interventional Management of Acute Pulmonary Embolism

Clinicians who diagnose and treat patients with acute pulmonary embolism (PE) need to be updated on guidelines and trials regarding the current interventional therapeutic landscape, particularly with catheter-directed devices. In this targeted 30-minute CME touchpoint, Dr. Adrian Messerli from UK HealthCare discusses the latest recommendations for the management of PE. This interactive activity will feature images, easy-to-read charts and graphs as well as expert video commentary. Featured...

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map